Murali Ramachandra, Aurigene Oncology CEO
Dr. Reddy's subsidiary hits the pause button on drug development for psoriasis
A biotech subsidiary of the India-based pharma company Dr. Reddy’s Laboratories is halting the development of a psoriasis drug.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
